|Bid||174.00 x 1000|
|Ask||174.29 x 800|
|Day's range||170.51 - 179.58|
|52-week range||59.29 - 331.68|
|Beta (5Y monthly)||1.55|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2021 - 13 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||258.00|
Covid jabs for billions of humans will earn their makers billions of dollars. We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive
One scorching-hot company that you'll strongly want to consider adding to your portfolio this summer is social media superstar Pinterest (NYSE: PINS). To state the obvious, Pinterest benefited immensely from the pandemic. This meant spending more time posting about what interests them on Pinterest, as well as perusing the interests of others on the site.
Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have remained a step ahead of most potential coronavirus vaccine rivals. Novavax (NASDAQ: NVAX) plans to submit its coronavirus vaccine candidate for emergency authorization in various countries including the U.S. in the third quarter. Now the question is whether Novavax has what it takes to join leaders Pfizer and Moderna at the top.